Cowen Starts Acrivon Therapeutics Inc (ACRV) at Outperform
Get Alerts ACRV Hot Sheet
Price: $1.72 --0%
Rating Summary:
10 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 9 | New: 6
Rating Summary:
10 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 9 | New: 6
Join SI Premium – FREE
Cowen analyst Joseph Thome initiates coverage on Acrivon Therapeutics Inc (NASDAQ: ACRV) with a Outperform rating.
For an analyst ratings summary and ratings history on Acrivon Therapeutics Inc click here. For more ratings news on Acrivon Therapeutics Inc click here.
Shares of Acrivon Therapeutics Inc closed at $12.50 yesterday.
You May Also Be Interested In
- Acrivon Therapeutics, Inc. (ACRV) Tops Q2 EPS by 21c
- Acrivon Reports Second Quarter 2026 Financial Results and Highlights Upcoming 2026 Clinical Data Catalysts
- Morgan Stanley Starts Achieve Life Sciences (ACHV) at Overweight
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share